| Phase 4 |
| NCT07093931 |
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2… |
Breast Cancer |
Not Yet Recruiting |
| Phase 3 |
| NCT04829708 |
Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in… |
Limited Stage Small Cell Lung Cancer |
Recruiting |
| NCT06841172 |
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line… |
OligoProgressive Metastatic Disease |
Recruiting |
| NCT07333274 |
Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible… |
Head & Neck Squamous Cell Carcinoma |
Recruiting |
| NCT06850090 |
Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102… |
Rectal Cancer |
Recruiting |
| NCT07686640 |
Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab… |
Local Advanced Rectal Cancer |
Not Yet Recruiting |
| Phase 2 |
| NCT05933967 |
A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression… |
The First Affiliated Hospital of Nanchang University |
Recruiting |
| NCT06241807 |
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC |
IMMUNOTHERAPY |
Recruiting |
| NCT06816771 |
Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for… |
Rhabdomyosarcoma, Recurrent, Refractory |
Recruiting |
| NCT06942416 |
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent… |
Cervical Cancer |
Recruiting |
| NCT06802757 |
Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in… |
Breast Cancer |
Recruiting |
| NCT06532539 |
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma |
Endometrial Neoplasms |
Recruiting |
| NCT06356584 |
Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of… |
Colorectal Cancer |
Recruiting |
| NCT06778382 |
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary… |
Colorectal Neoplasms Malignant |
Recruiting |
| NCT07274774 |
SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma |
Hepatocellular Carcinoma |
Recruiting |
| NCT06050317 |
Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable… |
Pancreas Cancer |
Recruiting |
| NCT07062055 |
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With… |
Hepatocellular Carcinoma |
Recruiting |
| NCT07026422 |
Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally… |
Rectal Malignant Neoplasms |
Recruiting |
| NCT07600268 |
Efficacy of Stereotactic Body Radiotherapy (SBRT) Combined With Maintenance Therapy… |
Pancreatic Cancer Non-resectable |
Recruiting |
| NCT06714266 |
Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or… |
Head and Neck Squamous Cell Carcinoma (HNSCC) |
Not Yet Recruiting |
| NCT07173387 |
Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer |
Pancreatic Cancer |
Active, Not Recruiting |
| NCT07669051 |
A Phase II Clinical Trial of Ivonescimab Plus Third-generation EGFR-TKIs in Advanced… |
NSCLC (Advanced Non-small Cell Lung Cancer) |
Active, Not Recruiting |
| NCT07683221 |
SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally… |
Pancreatic Cancer |
Not Yet Recruiting |
| Phase 1/2 |
| NCT06847555 |
Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of… |
To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients |
Recruiting |
| NCT06844422 |
Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement… |
Pancreatic Cancer |
Recruiting |